Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Journal of Personalized Medicine
Volume 11, Issue 12, Pages 1335
Publisher
MDPI AG
Online
2021-12-10
DOI
10.3390/jpm11121335
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor-Induced Inflammatory Cytokines and the Emerging Diagnostic Devices for Cancer Detection and Prognosis
- (2021) Apriliana E. R. Kartikasari et al. Frontiers in Oncology
- Decrease in Neutrophil-to-Lymphocyte Ratio during Neoadjuvant Chemotherapy as a Predictive and Prognostic Marker in Advanced Ovarian Cancer
- (2021) Elisabetta Sanna et al. Diagnostics
- Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer
- (2020) Nirmala Chandralega Kampan et al. Scientific Reports
- Ovarian Cancer in the Elderly: Time to Move towards a More Logical Approach to Improve Prognosis—A Study from the FRANCOGYN Group
- (2020) Ludivine Dion et al. Journal of Clinical Medicine
- IL6, IL8, and IL10 in the distinction of malignant ovarian neoplasms and endometriomas
- (2020) Paula Carolina Arvelos Crispim et al. AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Serum cytokines and CXCR2: potential tumour markers in ovarian neoplasms
- (2020) Douglas Côbo Micheli et al. BIOMARKERS
- Impact of age‐, cancer‐, and treatment‐driven inflammation on T cell function and immunotherapy
- (2020) Kylie M. Quinn et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Cancer Genetics
- (2020) Christine Van Cott SURGICAL CLINICS OF NORTH AMERICA
- Prognostic and Clinical Value of Interleukin 6 and CD45+CD14+ Inflammatory Cells with PD-L1+/PD-L2+ Expression in Patients with Different Manifestation of Ovarian Cancer
- (2020) Iwona Wertel et al. Journal of Immunology Research
- Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels
- (2019) Alshymaa A. Ahmed et al. CURRENT PROBLEMS IN CANCER
- Cytokines in peritoneal fluid of ovarian neoplasms
- (2019) Cid Almeida de Lima et al. JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress
- (2019) Jun Shi et al. BMC CANCER
- IL-6 and IL-8 as Prognostic Factors in Peritoneal Fluid of Ovarian Cancer
- (2019) Isac Souza Silva Rodrigues et al. IMMUNOLOGICAL INVESTIGATIONS
- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients
- (2018) Venus Dalal et al. CLINICA CHIMICA ACTA
- IL-6 family cytokines: Key inflammatory mediators as biomarkers and potential therapeutic targets
- (2018) Nese Unver et al. CYTOKINE & GROWTH FACTOR REVIEWS
- A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
- (2018) Chanhee Han et al. GYNECOLOGIC ONCOLOGY
- IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
- (2018) Landon Browning et al. Cancer Management and Research
- Serum IL-6 and IL-8 Correlate with Prognostic Factors in Ovarian Cancer
- (2017) Marcela Moisés Maluf Sanguinete et al. IMMUNOLOGICAL INVESTIGATIONS
- Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer
- (2017) Juan Carlos Cantón-Romero et al. Oxidative Medicine and Cellular Longevity
- Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms
- (2017) A. Martins-Filho et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- The Surveillance, Epidemiology, and End Results (SEER) Program and Pathology
- (2016) Máire A. Duggan et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Effects of the balance between type 1 and type 2 T helper cells on ovarian cancer
- (2016) C.J. Hao et al. GENETICS AND MOLECULAR RESEARCH
- The revised 2014 FIGO staging system for epithelial ovarian cancer: Is a subclassification into FIGO stage IVA and IVB justified?
- (2016) Beyhan Ataseven et al. GYNECOLOGIC ONCOLOGY
- Biochemical composition of malignant ascites determines high aggressiveness of undifferentiated ovarian tumors
- (2016) Justyna Mikuła-Pietrasik et al. MEDICAL ONCOLOGY
- Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range
- (2016) Dehui Luo et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
- (2015) Denis Lane et al. BMC CANCER
- Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort
- (2015) J. Ose et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Plasma immune analytes in patients with epithelial ovarian cancer
- (2015) Matthew S. Block et al. CYTOKINE
- Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma
- (2015) Koji Matsuo et al. EUROPEAN JOURNAL OF CANCER
- Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions
- (2015) Anita Chudecka-Glaz et al. OncoTargets and Therapy
- Hereditary Ovarian Cancer: Not OnlyBRCA1 and 2 Genes
- (2015) Angela Toss et al. Biomed Research International
- Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial
- (2014) Britton Trabert et al. GYNECOLOGIC ONCOLOGY
- A Prospective Study of Circulating C-Reactive Protein, Interleukin-6, and Tumor Necrosis Factor α Receptor 2 Levels and Risk of Ovarian Cancer
- (2013) Elizabeth M. Poole et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women
- (2012) Dominic J Autelitano et al. Journal of Translational Medicine
- Immune Response Evaluation Through Determination of Type 1, Type 2, and Type 17 Patterns in Patients With Epithelial Ovarian Cancer
- (2012) Eduardo Batista Cândido et al. Reproductive Sciences
- Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age
- (2011) Richard G. Moore et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Recent progress in the diagnosis and treatment of ovarian cancer
- (2011) Danijela Jelovac et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Circulating Inflammation Markers and Risk of Epithelial Ovarian Cancer
- (2011) T. V. Clendenen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Cytokine analysis as a tool to understand tumour–host interaction in ovarian cancer
- (2011) Refika Yigit et al. EUROPEAN JOURNAL OF CANCER
- Ovarian Cancer Development and Metastasis
- (2010) Ernst Lengyel AMERICAN JOURNAL OF PATHOLOGY
- Phase II biomarker trial of a multimarker diagnostic for ovarian cancer
- (2010) Tracey Edgell et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data
- (2009) Byron C Wallace et al. BMC Medical Research Methodology
- p53 autoantibodies, cytokine levels and ovarian carcinogenesis
- (2009) Miyun Tsai-Turton et al. GYNECOLOGIC ONCOLOGY
- Ovarian cancer cytoreduction induces changes in T cell population subsets reducing immunosuppression
- (2009) Chiara Napoletano et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer
- (2009) Suraj D. Amonkar et al. PLoS One
- Cytokine elevations in acute coronary syndrome and ovarian cancer: A mechanism for the up-regulation of the acute phase proteins in these different disease etiologies
- (2008) Peter A. Kavsak et al. CLINICAL BIOCHEMISTRY
- Interleukin-6 and leptin as markers of energy metabolicchanges in advanced ovarian cancer patients
- (2008) Antonio Macciò et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Interleukin-6, Cortisol, and Depressive Symptoms in Ovarian Cancer Patients
- (2008) Susan K. Lutgendorf et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started